Publications by authors named "Anne Laurence Best"
Article Synopsis
- * This study from 2021 to 2023 evaluated intense pulsed light (IPL) therapy in patients with moderate MGD and severe COSP, showing significant improvements in pain and eye health after three IPL sessions.
- * Results indicated not only reduced pain levels (measured by OSDI) at two and four months post-treatment, but also improved tear film stability and reduced meibomian gland obstruction, suggesting IPL may help address the neuropathic aspect of COSP in MGD.
Introduction: Dengue is an arboviral disease transmitted by the dengue virus, whose vectors are Aedes aegypti and Aedes albopictus. The acute phase with its cohort of well-known symptoms is usually spontaneously favorable. Since 2020 in Reunion Island, a new symptom has appeared: the ocular damage of dengue fever, which has already been described in South Asia and South-East Asia.
View Article and Find Full Text PDFObjectives: Peripheral ulcerative keratitis (PUK) is a severe corneal condition associated with uncontrolled RA. Tocilizumab (TCZ) is used to control RA, however, episodes of paradoxical ocular inflammation have been reported in TCZ-treated patients. We report a case series of PUK in TCZ-treated RA patients with ophthalmological and systemic findings and discuss the potential underlying mechanisms.
View Article and Find Full Text PDFArticle Synopsis
- This study evaluated the impact of a new intracameral combination of mydriatics and anesthetic (ICMA) on cataract surgery outcomes at a hospital in France, comparing results before and after its implementation.
- A retrospective review of three patient groups showed that while visual outcomes and complications remained stable, the duration of surgery and patient turnover times significantly decreased after ICMA was introduced.
- The findings suggest that using ICMA as a standard procedure improves efficiency in cataract surgery without compromising patient safety or vision results.
Aims: Diabetic macular edema (DME) frequently presents bilaterally. In case of bilateral retinal disease, the visual impairment (VI) and the visual acuity (VA) are strongly correlated to the better eye. The aim of this study was to assess the impact of ranibizumab intravitreal injections (IVR) on VI in patients with simultaneous VA loss due to DME.
View Article and Find Full Text PDFPurpose: To assess real-life efficacy of ranibizumab and treatment compliance of patients with vision loss secondary to diabetic macular edema (DME).
Methods: A retrospective study was conducted in DME patients treated with ranibizumab. Patients were monitored every 4 weeks for visual acuity (VA) and central retinal thickness (CRT) by SD-OCT.